A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old
PHASE3
The study will include newly-diagnosed AML patients, not suffering acute pr...
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
PHASE2
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
PHASE2
This prospective, multi-center, randomized, controlled Phase II study is to...
Status
Recruiting
Location
The First Affliated Hospital of Soochow University